Lixte Biotechnology Holdings Inc (LIXT) Stock: Tracking the Weekly Performance

The stock of Lixte Biotechnology Holdings Inc (LIXT) has gone up by 37.47% for the week, with a 25.51% rise in the past month and a 35.37% rise in the past quarter. The volatility ratio for the week is 28.06%, and the volatility levels for the past 30 days are 11.51% for LIXT. The simple moving average for the past 20 days is 19.41% for LIXT’s stock, with a 9.00% simple moving average for the past 200 days.

Is It Worth Investing in Lixte Biotechnology Holdings Inc (NASDAQ: LIXT) Right Now?

The 36-month beta value for LIXT is also noteworthy at -0.30. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for LIXT is 1.73M, and at present, short sellers hold a 1.13% of that float. The average trading volume of LIXT on April 04, 2024 was 561.80K shares.

LIXT) stock’s latest price update

Lixte Biotechnology Holdings Inc (NASDAQ: LIXT)’s stock price has gone decline by -16.22 in comparison to its previous close of 3.70, however, the company has experienced a 37.47% increase in its stock price over the last five trading days. PennyStocks reported 2023-02-13 that Here’s some tips for sustainably investing in penny stocks The post How to Sustainably Invest in Penny Stocks  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

LIXT Trading at 27.65% from the 50-Day Moving Average

After a stumble in the market that brought LIXT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -67.71% of loss for the given period.

Volatility was left at 11.51%, however, over the last 30 days, the volatility rate increased by 28.06%, as shares surge +26.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +44.86% upper at present.

During the last 5 trading sessions, LIXT rose by +37.47%, which changed the moving average for the period of 200-days by -34.74% in comparison to the 20-day moving average, which settled at $2.63. In addition, Lixte Biotechnology Holdings Inc saw 31.91% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at LIXT starting from van der Baan Bastiaan Jeroen, who purchase 10,000 shares at the price of $2.80 back on Oct 03 ’23. After this action, van der Baan Bastiaan Jeroen now owns 11,000 shares of Lixte Biotechnology Holdings Inc, valued at $28,000 using the latest closing price.

Stock Fundamentals for LIXT

The total capital return value is set at -1.27. Equity return is now at value -111.07, with -103.09 for asset returns.

Currently, EBITDA for the company is -5.09 million with net debt to EBITDA at 0.83. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.48.

Conclusion

In summary, Lixte Biotechnology Holdings Inc (LIXT) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts